Intellectual Property Protection
To translate our bench work to market, we have conducted market analysis through the NSERC Lab2Market grant and participated in the University of Toronto early-stage technologies program (UTEST; 2022). Due to the novelty of our discovery, we have filed a PCT patent (pending) for the use of ZAP-100™ as an appetite suppressant.
Updated